
According to this study, over the next five years the Cephalosporin market will register a 2.0%% CAGR in terms of revenue, the global market size will reach $ 4056.8 million by 2025, from $ 3752.2 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cephalosporin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Cephalosporin market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Cephalosporin, covering the supply chain analysis, impact assessment to the Cephalosporin market size growth rate in several scenarios, and the measures to be undertaken by Cephalosporin companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
First Generation
Second Generation
Third Generation
Fourth Generation
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Oral
Injection
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Union Chempharma
SALUBRIS
NCPC
Lupin Pharmaceuticals
Hospira
Qilu Antibiotics
Dongying Pharmaceutical
Dhanuka Laboratories
Alkem
Fukang
Taj Pharmaceuticals
United Laboratories
Covalent Laboratories
LIVZON
TEVA
CSPC
Wockhardt
Orchid Pharma
Hetero Drugs
Aurobindo
HPGC
Huafangpharm
LKPC
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cephalosporin consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Cephalosporin market by identifying its various subsegments.
Focuses on the key global Cephalosporin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cephalosporin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cephalosporin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cephalosporin Consumption 2015-2025
2.1.2 Cephalosporin Consumption CAGR by Region
2.2 Cephalosporin Segment by Type
2.2.1 First Generation
2.2.2 Second Generation
2.2.3 Third Generation
2.2.4 Fourth Generation
2.3 Cephalosporin Consumption by Type
2.3.1 Global Cephalosporin Consumption Market Share by Type (2015-2020)
2.3.2 Global Cephalosporin Revenue and Market Share by Type (2015-2020)
2.3.3 Global Cephalosporin Sale Price by Type (2015-2020)
2.4 Cephalosporin Segment by Application
2.4.1 Oral
2.4.2 Injection
2.5 Cephalosporin Consumption by Application
2.5.1 Global Cephalosporin Consumption Market Share by Type (2015-2020)
2.5.2 Global Cephalosporin Value and Market Share by Type (2015-2020)
2.5.3 Global Cephalosporin Sale Price by Type (2015-2020)
3 Global Cephalosporin by Company
3.1 Global Cephalosporin Sales Market Share by Company
3.1.1 Global Cephalosporin Sales by Company (2018-2020)
3.1.2 Global Cephalosporin Sales Market Share by Company (2018-2020)
3.2 Global Cephalosporin Revenue Market Share by Company
3.2.1 Global Cephalosporin Revenue by Company (2018-2020)
3.2.2 Global Cephalosporin Revenue Market Share by Company (2018-2020)
3.3 Global Cephalosporin Sale Price by Company
3.4 Global Cephalosporin Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Cephalosporin Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Cephalosporin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Cephalosporin by Regions
4.1 Cephalosporin by Regions
4.2 Americas Cephalosporin Consumption Growth
4.3 APAC Cephalosporin Consumption Growth
4.4 Europe Cephalosporin Consumption Growth
4.5 Middle East & Africa Cephalosporin Consumption Growth
5 Americas
5.1 Americas Cephalosporin Consumption by Countries
5.1.1 Americas Cephalosporin Consumption by Countries (2015-2020)
5.1.2 Americas Cephalosporin Value by Countries (2015-2020)
5.2 Americas Cephalosporin Consumption by Type
5.3 Americas Cephalosporin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Cephalosporin Consumption by Regions
6.1.1 APAC Cephalosporin Consumption by Regions (2015-2020)
6.1.2 APAC Cephalosporin Value by Regions (2015-2020)
6.2 APAC Cephalosporin Consumption by Type
6.3 APAC Cephalosporin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Cephalosporin by Countries
7.1.1 Europe Cephalosporin Consumption by Countries (2015-2020)
7.1.2 Europe Cephalosporin Value by Countries (2015-2020)
7.2 Europe Cephalosporin Consumption by Type
7.3 Europe Cephalosporin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Cephalosporin by Countries
8.1.1 Middle East & Africa Cephalosporin Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Cephalosporin Value by Countries (2015-2020)
8.2 Middle East & Africa Cephalosporin Consumption by Type
8.3 Middle East & Africa Cephalosporin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cephalosporin Distributors
10.3 Cephalosporin Customer
11 Global Cephalosporin Market Forecast
11.1 Global Cephalosporin Consumption Forecast (2021-2025)
11.2 Global Cephalosporin Forecast by Regions
11.2.1 Global Cephalosporin Forecast by Regions (2021-2025)
11.2.2 Global Cephalosporin Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Cephalosporin Forecast by Type
11.8 Global Cephalosporin Forecast by Application
12 Key Players Analysis
12.1 Union Chempharma
12.1.1 Company Information
12.1.2 Cephalosporin Product Offered
12.1.3 Union Chempharma Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Union Chempharma Latest Developments
12.2 SALUBRIS
12.2.1 Company Information
12.2.2 Cephalosporin Product Offered
12.2.3 SALUBRIS Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 SALUBRIS Latest Developments
12.3 NCPC
12.3.1 Company Information
12.3.2 Cephalosporin Product Offered
12.3.3 NCPC Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 NCPC Latest Developments
12.4 Lupin Pharmaceuticals
12.4.1 Company Information
12.4.2 Cephalosporin Product Offered
12.4.3 Lupin Pharmaceuticals Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Lupin Pharmaceuticals Latest Developments
12.5 Hospira
12.5.1 Company Information
12.5.2 Cephalosporin Product Offered
12.5.3 Hospira Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Hospira Latest Developments
12.6 Qilu Antibiotics
12.6.1 Company Information
12.6.2 Cephalosporin Product Offered
12.6.3 Qilu Antibiotics Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Qilu Antibiotics Latest Developments
12.7 Dongying Pharmaceutical
12.7.1 Company Information
12.7.2 Cephalosporin Product Offered
12.7.3 Dongying Pharmaceutical Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Dongying Pharmaceutical Latest Developments
12.8 Dhanuka Laboratories
12.8.1 Company Information
12.8.2 Cephalosporin Product Offered
12.8.3 Dhanuka Laboratories Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Dhanuka Laboratories Latest Developments
12.9 Alkem
12.9.1 Company Information
12.9.2 Cephalosporin Product Offered
12.9.3 Alkem Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Alkem Latest Developments
12.10 Fukang
12.10.1 Company Information
12.10.2 Cephalosporin Product Offered
12.10.3 Fukang Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Fukang Latest Developments
12.11 Taj Pharmaceuticals
12.11.1 Company Information
12.11.2 Cephalosporin Product Offered
12.11.3 Taj Pharmaceuticals Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Taj Pharmaceuticals Latest Developments
12.12 United Laboratories
12.12.1 Company Information
12.12.2 Cephalosporin Product Offered
12.12.3 United Laboratories Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 United Laboratories Latest Developments
12.13 Covalent Laboratories
12.13.1 Company Information
12.13.2 Cephalosporin Product Offered
12.13.3 Covalent Laboratories Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Covalent Laboratories Latest Developments
12.14 LIVZON
12.14.1 Company Information
12.14.2 Cephalosporin Product Offered
12.14.3 LIVZON Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 LIVZON Latest Developments
12.15 TEVA
12.15.1 Company Information
12.15.2 Cephalosporin Product Offered
12.15.3 TEVA Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 TEVA Latest Developments
12.16 CSPC
12.16.1 Company Information
12.16.2 Cephalosporin Product Offered
12.16.3 CSPC Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 CSPC Latest Developments
12.17 Wockhardt
12.17.1 Company Information
12.17.2 Cephalosporin Product Offered
12.17.3 Wockhardt Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Wockhardt Latest Developments
12.18 Orchid Pharma
12.18.1 Company Information
12.18.2 Cephalosporin Product Offered
12.18.3 Orchid Pharma Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Orchid Pharma Latest Developments
12.19 Hetero Drugs
12.19.1 Company Information
12.19.2 Cephalosporin Product Offered
12.19.3 Hetero Drugs Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Hetero Drugs Latest Developments
12.20 Aurobindo
12.20.1 Company Information
12.20.2 Cephalosporin Product Offered
12.20.3 Aurobindo Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Aurobindo Latest Developments
12.21 HPGC
12.21.1 Company Information
12.21.2 Cephalosporin Product Offered
12.21.3 HPGC Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 HPGC Latest Developments
12.22 Huafangpharm
12.22.1 Company Information
12.22.2 Cephalosporin Product Offered
12.22.3 Huafangpharm Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.22.4 Main Business Overview
12.22.5 Huafangpharm Latest Developments
12.23 LKPC
12.23.1 Company Information
12.23.2 Cephalosporin Product Offered
12.23.3 LKPC Cephalosporin Sales, Revenue, Price and Gross Margin (2018-2020)
12.23.4 Main Business Overview
12.23.5 LKPC Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Cephalosporin Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of First Generation
Table 5. Major Players of Second Generation
Table 6. Major Players of Third Generation
Table 7. Major Players of Fourth Generation
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Cephalosporin Consumption Market Share by Type (2015-2020)
Table 10. Global Cephalosporin Revenue by Type (2015-2020) ($ million)
Table 11. Global Cephalosporin Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Cephalosporin Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Cephalosporin Consumption Market Share by Application (2015-2020)
Table 15. Global Cephalosporin Value by Application (2015-2020)
Table 16. Global Cephalosporin Value Market Share by Application (2015-2020)
Table 17. Global Cephalosporin Sale Price by Application (2015-2020)
Table 18. Global Cephalosporin Sales by Company (2017-2019) (MT)
Table 19. Global Cephalosporin Sales Market Share by Company (2017-2019)
Table 20. Global Cephalosporin Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Cephalosporin Revenue Market Share by Company (2017-2019)
Table 22. Global Cephalosporin Sale Price by Company (2017-2019)
Table 23. Global Cephalosporin Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Cephalosporin Products Offered
Table 25. Cephalosporin Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Cephalosporin Consumption by Regions 2015-2020 (MT)
Table 27. Global Cephalosporin Consumption Market Share by Regions 2015-2020
Table 28. Global Cephalosporin Value by Regions 2015-2020 ($ Millions)
Table 29. Global Cephalosporin Value Market Share by Regions 2015-2020
Table 30. Americas Cephalosporin Consumption by Countries (2015-2020) (MT)
Table 31. Americas Cephalosporin Consumption Market Share by Countries (2015-2020)
Table 32. Americas Cephalosporin Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Cephalosporin Value Market Share by Countries (2015-2020)
Table 34. Americas Cephalosporin Consumption by Type (2015-2020) (MT)
Table 35. Americas Cephalosporin Consumption Market Share by Type (2015-2020)
Table 36. Americas Cephalosporin Consumption by Application (2015-2020) (MT)
Table 37. Americas Cephalosporin Consumption Market Share by Application (2015-2020)
Table 38. APAC Cephalosporin Consumption by Countries (2015-2020) (MT)
Table 39. APAC Cephalosporin Consumption Market Share by Countries (2015-2020)
Table 40. APAC Cephalosporin Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Cephalosporin Value Market Share by Regions (2015-2020)
Table 42. APAC Cephalosporin Consumption by Type (2015-2020) (MT)
Table 43. APAC Cephalosporin Consumption Market Share by Type (2015-2020)
Table 44. APAC Cephalosporin Consumption by Application (2015-2020) (MT)
Table 45. APAC Cephalosporin Consumption Market Share by Application (2015-2020)
Table 46. Europe Cephalosporin Consumption by Countries (2015-2020) (MT)
Table 47. Europe Cephalosporin Consumption Market Share by Countries (2015-2020)
Table 48. Europe Cephalosporin Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Cephalosporin Value Market Share by Countries (2015-2020)
Table 50. Europe Cephalosporin Consumption by Type (2015-2020) (MT)
Table 51. Europe Cephalosporin Consumption Market Share by Type (2015-2020)
Table 52. Europe Cephalosporin Consumption by Application (2015-2020) (MT)
Table 53. Europe Cephalosporin Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Cephalosporin Consumption by Countries (2015-2020) (MT)
Table 55. Middle East & Africa Cephalosporin Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Cephalosporin Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Cephalosporin Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Cephalosporin Consumption by Type (2015-2020) (MT)
Table 59. Middle East & Africa Cephalosporin Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Cephalosporin Consumption by Application (2015-2020) (MT)
Table 61. Middle East & Africa Cephalosporin Consumption Market Share by Application (2015-2020)
Table 62. Cephalosporin Distributors List
Table 63. Cephalosporin Customer List
Table 64. Global Cephalosporin Consumption Forecast by Countries (2021-2025) (MT)
Table 65. Global Cephalosporin Consumption Market Forecast by Regions
Table 66. Global Cephalosporin Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Cephalosporin Value Market Share Forecast by Regions
Table 68. Global Cephalosporin Consumption Forecast by Type (2021-2025) (MT)
Table 69. Global Cephalosporin Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Cephalosporin Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Cephalosporin Value Market Share Forecast by Type (2021-2025)
Table 72. Global Cephalosporin Consumption Forecast by Application (2021-2025) (MT)
Table 73. Global Cephalosporin Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Cephalosporin Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Cephalosporin Value Market Share Forecast by Application (2021-2025)
Table 76. Union Chempharma Product Offered
Table 77. Union Chempharma Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 78. Union Chempharma Main Business
Table 79. Union Chempharma Latest Developments
Table 80. Union Chempharma Basic Information, Company Total Revenue (in $ million), Cephalosporin Manufacturing Base, Sales Area and Its Competitors
Table 81. SALUBRIS Product Offered
Table 82. SALUBRIS Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 83. SALUBRIS Main Business
Table 84. SALUBRIS Latest Developments
Table 85. SALUBRIS Basic Information, Company Total Revenue (in $ million), Cephalosporin Manufacturing Base, Sales Area and Its Competitors
Table 86. NCPC Product Offered
Table 87. NCPC Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 88. NCPC Main Business
Table 89. NCPC Latest Developments
Table 90. NCPC Basic Information, Company Total Revenue (in $ million), Cephalosporin Manufacturing Base, Sales Area and Its Competitors
Table 91. Lupin Pharmaceuticals Product Offered
Table 92. Lupin Pharmaceuticals Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 93. Lupin Pharmaceuticals Main Business
Table 94. Lupin Pharmaceuticals Latest Developments
Table 95. Lupin Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Cephalosporin Manufacturing Base, Sales Area and Its Competitors
Table 96. Hospira Product Offered
Table 97. Hospira Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 98. Hospira Main Business
Table 99. Hospira Latest Developments
Table 100. Hospira Basic Information, Company Total Revenue (in $ million), Cephalosporin Manufacturing Base, Sales Area and Its Competitors
Table 101. Qilu Antibiotics Product Offered
Table 102. Qilu Antibiotics Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 103. Qilu Antibiotics Main Business
Table 104. Qilu Antibiotics Latest Developments
Table 105. Qilu Antibiotics Basic Information, Company Total Revenue (in $ million), Cephalosporin Manufacturing Base, Sales Area and Its Competitors
Table 106. Dongying Pharmaceutical Product Offered
Table 107. Dongying Pharmaceutical Basic Information, Company Total Revenue (in $ million), Cephalosporin Manufacturing Base, Sales Area and Its Competitors
Table 108. Dongying Pharmaceutical Main Business
Table 109. Dongying Pharmaceutical Latest Developments
Table 110. Dongying Pharmaceutical Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 111. Dhanuka Laboratories Product Offered
Table 112. Dhanuka Laboratories Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 113. Dhanuka Laboratories Main Business
Table 114. Dhanuka Laboratories Latest Developments
Table 115. Dhanuka Laboratories Basic Information, Company Total Revenue (in $ million), Cephalosporin Manufacturing Base, Sales Area and Its Competitors
Table 116. Alkem Product Offered
Table 117. Alkem Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 118. Alkem Main Business
Table 119. Alkem Latest Developments
Table 120. Alkem Basic Information, Company Total Revenue (in $ million), Cephalosporin Manufacturing Base, Sales Area and Its Competitors
Table 121. Fukang Product Offered
Table 122. Fukang Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 123. Fukang Main Business
Table 124. Fukang Latest Developments
Table 125. Fukang Basic Information, Company Total Revenue (in $ million), Cephalosporin Manufacturing Base, Sales Area and Its Competitors
Table 126. Taj Pharmaceuticals Product Offered
Table 127. Taj Pharmaceuticals Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 128. Taj Pharmaceuticals Main Business
Table 129. Taj Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Taj Pharmaceuticals Latest Developments
Table 131. United Laboratories Product Offered
Table 132. United Laboratories Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 133. United Laboratories Main Business
Table 134. United Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. United Laboratories Latest Developments
Table 136. Covalent Laboratories Product Offered
Table 137. Covalent Laboratories Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 138. Covalent Laboratories Main Business
Table 139. Covalent Laboratories Latest Developments
Table 140. Covalent Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 141. LIVZON Product Offered
Table 142. LIVZON Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 143. LIVZON Main Business
Table 144. LIVZON Latest Developments
Table 145. LIVZON Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 146. TEVA Product Offered
Table 147. TEVA Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 148. TEVA Main Business
Table 149. TEVA Latest Developments
Table 150. TEVA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 151. CSPC Product Offered
Table 152. CSPC Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 153. CSPC Main Business
Table 154. CSPC Latest Developments
Table 155. CSPC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 156. Wockhardt Product Offered
Table 157. Wockhardt Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 158. Wockhardt Main Business
Table 159. Wockhardt Latest Developments
Table 160. Wockhardt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 161. Orchid Pharma Product Offered
Table 162. Orchid Pharma Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 163. Orchid Pharma Main Business
Table 164. Orchid Pharma Latest Developments
Table 165. Orchid Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 166. Hetero Drugs Product Offered
Table 167. Hetero Drugs Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 168. Hetero Drugs Main Business
Table 169. Hetero Drugs Latest Developments
Table 170. Hetero Drugs Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 171. Aurobindo Product Offered
Table 172. Aurobindo Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 173. Aurobindo Main Business
Table 174. Aurobindo Latest Developments
Table 175. Aurobindo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 176. HPGC Product Offered
Table 177. HPGC Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 178. HPGC Main Business
Table 179. HPGC Latest Developments
Table 180. HPGC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 181. Huafangpharm Product Offered
Table 182. Huafangpharm Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 183. Huafangpharm Main Business
Table 184. Huafangpharm Latest Developments
Table 185. Huafangpharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 186. LKPC Product Offered
Table 187. LKPC Cephalosporin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 188. LKPC Main Business
Table 189. LKPC Latest Developments
Table 190. LKPC Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Cephalosporin
Figure 2. Cephalosporin Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Cephalosporin Consumption Growth Rate 2015-2025 (MT)
Figure 5. Global Cephalosporin Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of First Generation
Figure 7. Product Picture of Second Generation
Figure 8. Product Picture of Third Generation
Figure 9. Product Picture of Fourth Generation
Figure 10. Global Cephalosporin Consumption Market Share by Type (2015-2020)
Figure 11. Global Cephalosporin Value Market Share by Type (2015-2020)
Figure 12. Cephalosporin Consumed in Oral
Figure 13. Global Cephalosporin Market: Oral (2015-2020) (MT)
Figure 14. Global Cephalosporin Market: Oral (2015-2020) ($ Millions)
Figure 15. Cephalosporin Consumed in Injection
Figure 16. Global Cephalosporin Market: Injection (2015-2020) (MT)
Figure 17. Global Cephalosporin Market: Injection (2015-2020) ($ Millions)
Figure 18. Global Cephalosporin Consumption Market Share by Application (2015-2020)
Figure 19. Global Cephalosporin Value Market Share by Application (2015-2020)
Figure 20. Global Cephalosporin Sales Market Share by Company in 2017
Figure 21. Global Cephalosporin Sales Market Share by Company in 2019
Figure 22. Global Cephalosporin Revenue Market Share by Company in 2017
Figure 23. Global Cephalosporin Revenue Market Share by Company in 2019
Figure 24. Global Cephalosporin Sale Price by Company in 2019
Figure 25. Global Cephalosporin Consumption Market Share by Regions 2015-2020
Figure 26. Global Cephalosporin Value Market Share by Regions 2015-2020
Figure 27. Americas Cephalosporin Consumption 2015-2020 (MT)
Figure 28. Americas Cephalosporin Value 2015-2020 ($ Millions)
Figure 29. APAC Cephalosporin Consumption 2015-2020 (MT)
Figure 30. APAC Cephalosporin Value 2015-2020 ($ Millions)
Figure 31. Europe Cephalosporin Consumption 2015-2020 (MT)
Figure 32. Europe Cephalosporin Value 2015-2020 ($ Millions)
Figure 33. Middle East & Africa Cephalosporin Consumption 2015-2020 (MT)
Figure 34. Middle East & Africa Cephalosporin Value 2015-2020 ($ Millions)
Figure 35. Americas Cephalosporin Consumption Market Share by Countries in 2019
Figure 36. Americas Cephalosporin Value Market Share by Countries in 2019
Figure 37. Americas Cephalosporin Consumption Market Share by Type in 2019
Figure 38. Americas Cephalosporin Consumption Market Share by Application in 2019
Figure 39. United States Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 40. United States Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 41. Canada Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 42. Canada Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 43. Mexico Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 44. Mexico Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 45. APAC Cephalosporin Consumption Market Share by Countries in 2019
Figure 46. APAC Cephalosporin Value Market Share by Regions in 2019
Figure 47. APAC Cephalosporin Consumption Market Share by Type in 2019
Figure 48. APAC Cephalosporin Consumption Market Share by Application in 2019
Figure 49. China Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 50. China Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 51. Japan Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 52. Japan Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 53. Korea Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 54. Korea Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 55. Southeast Asia Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 56. Southeast Asia Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 57. India Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 58. India Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 59. Australia Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 60. Australia Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 61. Europe Cephalosporin Consumption Market Share by Countries in 2019
Figure 62. Europe Cephalosporin Value Market Share by Countries in 2019
Figure 63. Europe Cephalosporin Consumption Market Share by Type in 2019
Figure 64. Europe Cephalosporin Consumption Market Share by Application in 2019
Figure 65. Germany Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 66. Germany Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 67. France Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 68. France Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 69. UK Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 70. UK Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 71. Italy Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 72. Italy Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 73. Russia Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 74. Russia Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 75. Middle East & Africa Cephalosporin Consumption Market Share by Countries in 2019
Figure 76. Middle East & Africa Cephalosporin Value Market Share by Countries in 2019
Figure 77. Middle East & Africa Cephalosporin Consumption Market Share by Type in 2019
Figure 78. Middle East & Africa Cephalosporin Consumption Market Share by Application in 2019
Figure 79. Egypt Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 80. Egypt Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 81. South Africa Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 82. South Africa Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 83. Israel Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 84. Israel Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 85. Turkey Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 86. Turkey Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 87. GCC Countries Cephalosporin Consumption Growth 2015-2020 (MT)
Figure 88. GCC Countries Cephalosporin Value Growth 2015-2020 ($ Millions)
Figure 89. Global Cephalosporin Consumption Growth Rate Forecast (2021-2025) (MT)
Figure 90. Global Cephalosporin Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 91. Americas Cephalosporin Consumption 2021-2025 (MT)
Figure 92. Americas Cephalosporin Value 2021-2025 ($ Millions)
Figure 93. APAC Cephalosporin Consumption 2021-2025 (MT)
Figure 94. APAC Cephalosporin Value 2021-2025 ($ Millions)
Figure 95. Europe Cephalosporin Consumption 2021-2025 (MT)
Figure 96. Europe Cephalosporin Value 2021-2025 ($ Millions)
Figure 97. Middle East & Africa Cephalosporin Consumption 2021-2025 (MT)
Figure 98. Middle East & Africa Cephalosporin Value 2021-2025 ($ Millions)
Figure 99. United States Cephalosporin Consumption 2021-2025 (MT)
Figure 100. United States Cephalosporin Value 2021-2025 ($ Millions)
Figure 101. Canada Cephalosporin Consumption 2021-2025 (MT)
Figure 102. Canada Cephalosporin Value 2021-2025 ($ Millions)
Figure 103. Mexico Cephalosporin Consumption 2021-2025 (MT)
Figure 104. Mexico Cephalosporin Value 2021-2025 ($ Millions)
Figure 105. Brazil Cephalosporin Consumption 2021-2025 (MT)
Figure 106. Brazil Cephalosporin Value 2021-2025 ($ Millions)
Figure 107. China Cephalosporin Consumption 2021-2025 (MT)
Figure 108. China Cephalosporin Value 2021-2025 ($ Millions)
Figure 109. Japan Cephalosporin Consumption 2021-2025 (MT)
Figure 110. Japan Cephalosporin Value 2021-2025 ($ Millions)
Figure 111. Korea Cephalosporin Consumption 2021-2025 (MT)
Figure 112. Korea Cephalosporin Value 2021-2025 ($ Millions)
Figure 113. Southeast Asia Cephalosporin Consumption 2021-2025 (MT)
Figure 114. Southeast Asia Cephalosporin Value 2021-2025 ($ Millions)
Figure 115. India Cephalosporin Consumption 2021-2025 (MT)
Figure 116. India Cephalosporin Value 2021-2025 ($ Millions)
Figure 117. Australia Cephalosporin Consumption 2021-2025 (MT)
Figure 118. Australia Cephalosporin Value 2021-2025 ($ Millions)
Figure 119. Germany Cephalosporin Consumption 2021-2025 (MT)
Figure 120. Germany Cephalosporin Value 2021-2025 ($ Millions)
Figure 121. France Cephalosporin Consumption 2021-2025 (MT)
Figure 122. France Cephalosporin Value 2021-2025 ($ Millions)
Figure 123. UK Cephalosporin Consumption 2021-2025 (MT)
Figure 124. UK Cephalosporin Value 2021-2025 ($ Millions)
Figure 125. Italy Cephalosporin Consumption 2021-2025 (MT)
Figure 126. Italy Cephalosporin Value 2021-2025 ($ Millions)
Figure 127. Russia Cephalosporin Consumption 2021-2025 (MT)
Figure 128. Russia Cephalosporin Value 2021-2025 ($ Millions)
Figure 129. Spain Cephalosporin Consumption 2021-2025 (MT)
Figure 130. Spain Cephalosporin Value 2021-2025 ($ Millions)
Figure 131. Egypt Cephalosporin Consumption 2021-2025 (MT)
Figure 132. Egypt Cephalosporin Value 2021-2025 ($ Millions)
Figure 133. South Africa Cephalosporin Consumption 2021-2025 (MT)
Figure 134. South Africa Cephalosporin Value 2021-2025 ($ Millions)
Figure 135. Israel Cephalosporin Consumption 2021-2025 (MT)
Figure 136. Israel Cephalosporin Value 2021-2025 ($ Millions)
Figure 137. Turkey Cephalosporin Consumption 2021-2025 (MT)
Figure 138. Turkey Cephalosporin Value 2021-2025 ($ Millions)
Figure 139. GCC Countries Cephalosporin Consumption 2021-2025 (MT)
Figure 140. GCC Countries Cephalosporin Value 2021-2025 ($ Millions)
Figure 141. Union Chempharma Cephalosporin Market Share (2018-2020)
Figure 142. SALUBRIS Cephalosporin Market Share (2018-2020)
Figure 143. NCPC Cephalosporin Market Share (2018-2020)
Figure 144. Lupin Pharmaceuticals Cephalosporin Market Share (2018-2020)
Figure 145. Hospira Cephalosporin Market Share (2018-2020)
Figure 146. Qilu Antibiotics Cephalosporin Market Share (2018-2020)
Figure 147. Dongying Pharmaceutical Cephalosporin Market Share (2018-2020)
Figure 148. Dhanuka Laboratories Cephalosporin Market Share (2018-2020)
Figure 149. Alkem Cephalosporin Market Share (2018-2020)
Figure 150. Fukang Cephalosporin Market Share (2018-2020)
Figure 151. Taj Pharmaceuticals Cephalosporin Market Share (2018-2020)
Figure 152. United Laboratories Cephalosporin Market Share (2018-2020)
Figure 153. Covalent Laboratories Cephalosporin Market Share (2018-2020)
Figure 154. LIVZON Cephalosporin Market Share (2018-2020)
Figure 155. TEVA Cephalosporin Market Share (2018-2020)
Figure 156. CSPC Cephalosporin Market Share (2018-2020)
Figure 157. Wockhardt Cephalosporin Market Share (2018-2020)
Figure 158. Orchid Pharma Cephalosporin Market Share (2018-2020)
Figure 159. Hetero Drugs Cephalosporin Market Share (2018-2020)
Figure 160. Aurobindo Cephalosporin Market Share (2018-2020)
Figure 161. HPGC Cephalosporin Market Share (2018-2020)
Figure 162. Huafangpharm Cephalosporin Market Share (2018-2020)
Figure 163. LKPC Cephalosporin Market Share (2018-2020)
Reason to Buy